Covid Induced Telogen Effluvium: An Insight

January 2022 in “ Indian Dermatology Online Journal ”

Arun C Inamadar

telogen effluvium COVID-19 pro-inflammatory cytokines hair follicles microthrombi TE COVID

TLDR COVID-19 may cause temporary hair loss due to direct damage to hair follicles, but it usually gets better on its own.

The document discusses the connection between COVID-19 and a type of hair loss called telogen effluvium (TE), which is often triggered by significant stress. Observational studies cited in the document found hair loss in 20-25% of COVID-19 survivors. The exact mechanisms causing this hair loss are unclear, but may include pro-inflammatory cytokines, direct viral damage to hair follicles, and microthrombi formation. The document concludes that TE after COVID-19 is likely due to direct viral damage to hair follicles, is reversible, and typically improves without treatment. However, more research is needed to fully understand this condition.

View this study on journals.lww.com →

Discuss this study in the Community →

Research cited in this study

11 / 11 results

research Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?

4 citations, February 2022 in “Journal of Cosmetic Dermatology”

Monocytes might be linked to hair loss after COVID-19.

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

25 citations, August 2021 in “Irish Journal of Medical Science (1971 -)”

COVID-19 infection can significantly cause temporary hair loss.

research More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis

1250 citations, August 2021 in “Scientific Reports”

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms

28 citations, January 2021 in “Skin appendage disorders”

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

research Telogen Effluvium: A Sequela of COVID-19

58 citations, November 2020 in “International Journal of Dermatology”

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

35 citations, November 2020 in “Dermatologic Therapy”

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

research Acute Telogen Effluvium Associated with SARS-CoV-2 Infection

24 citations, August 2020 in “AJGP”

A woman's sudden hair loss was linked to her previous COVID-19 infection.

research Telogen Effluvium: A Review of the Literature

40 citations, May 2020 in “Cureus”

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

research Female Pattern Alopecia and Telogen Effluvium: Figuring Out Diffuse Alopecia

25 citations, June 2015 in “Seminars in Cutaneous Medicine and Surgery”

The article explains how to tell apart and treat two common causes of hair loss in women.

research Interleukin-1β Is Differentially Expressed by Human Dermal Papilla Cells in Response to PKC Activation and Is a Potent Inhibitor of Human Hair Follicle Growth in Organ Culture

38 citations, March 1997 in “Journal of interferon & cytokine research”

IL-1β inhibits human hair follicle growth.

research Telogen Effluvium Due to Recombinant Interferon Alpha-2b

45 citations, January 1992 in “Dermatology”

Half of the patients treated with a specific drug for skin cancer experienced hair loss not related to the drug's dosage.

Similar Research

5 / 1000+ results

research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

3 citations, April 2022 in “Clinical, Cosmetic and Investigational Dermatology”

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

research A Cross-Sectional Study on Post-Coronavirus Disease Hair Loss at a Tertiary Care Hospital

October 2023 in “Dermatology practical & conceptual”

Many patients experienced hair loss after COVID-19, with women affected more, starting on average 49 days post-infection.

research SARS-CoV-2 Infection as a Trigger for Telogen Effluvium: A Literature Review with Case-Based Clinical Evaluation Guidance

2 citations, July 2023 in “Life”

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

research Intermittent Chronic Telogen Effluvium With an Unusual Dermoscopic Finding Following COVID-19

2 citations, August 2022 in “Clinical Case Reports”

A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.

research Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?

4 citations, February 2022 in “Journal of Cosmetic Dermatology”

Monocytes might be linked to hair loss after COVID-19.

Covid Induced Telogen Effluvium: An Insight

Research cited in this study

research Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?

research COVID-19 Infection Is a Major Cause of Acute Telogen Effluvium

research More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis

research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms

research Telogen Effluvium: A Sequela of COVID-19

research Telogen Effluvium Related to Post Severe SARS-CoV-2 Infection: Clinical Aspects and Our Management Experience

research Acute Telogen Effluvium Associated with SARS-CoV-2 Infection

research Telogen Effluvium: A Review of the Literature

research Female Pattern Alopecia and Telogen Effluvium: Figuring Out Diffuse Alopecia

research Interleukin-1β Is Differentially Expressed by Human Dermal Papilla Cells in Response to PKC Activation and Is a Potent Inhibitor of Human Hair Follicle Growth in Organ Culture

research Telogen Effluvium Due to Recombinant Interferon Alpha-2b

Related Community Posts Join

community PSA: Most men who stay on Fin will see the sexual side effects go away. Stop the fear mongering

community I bought a microscope, how does my scalp/hairs look? I've been suffering diffuse thinning and hair loss after covid and never recovered (2 yrs ago) I eat healthy, in shape and workout.

community Anyone else realize how many younger guys are balding?

community What was your “f*ck I’m balding” story?

community Still shedding like this everyday 9 months straight on fin and min. Should I switch to dut?

community The Real Cause Of Androgenetic Alopecia

Similar Research

research Complementary Strategies to Promote Hair Regrowth in Post-COVID-19 Telogen Effluvium

research A Cross-Sectional Study on Post-Coronavirus Disease Hair Loss at a Tertiary Care Hospital

research SARS-CoV-2 Infection as a Trigger for Telogen Effluvium: A Literature Review with Case-Based Clinical Evaluation Guidance

research Intermittent Chronic Telogen Effluvium With an Unusual Dermoscopic Finding Following COVID-19

research Evaluation of Patients with Telogen Effluvium During the Pandemic: Are Monocytes Responsible for Post COVID-19 Telogen Effluvium?